Close Menu

NEW YORK (360Dx) – Abbott said today it has received CE marking for its Determine HBsAg 2 rapid diagnostic test used to detect hepatitis B surface antigen.

The firm said that the test provides results of HBV status in 15 minutes with an analytical sensitivity of 0.1 IU/mL, enabling clinicians to make prompt treatment decisions .

Abbott said that its rapid lateral flow immunoassay is highly sensitive, easy-to-use, and facilitates "linkage to care in every healthcare setting."

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost. 

Sponsored by
Sophia Genetics

This webinar will present the utility of a personalized in silico analytical approach for the routine clinical diagnosis of channelopathies and cardiomyopathies. 

Sponsored by

This webinar will discuss novel long-read transcript sequencing (LRTseq) methods for transcriptome annotation that could increase the efficiency and accuracy of future sequencing projects.